Hydrolysed inulin alleviates the azoxymethane-induced preneoplastic aberrant crypt foci by altering selected intestinal microbiota in Sprague–Dawley rats

Pharmaceutical Biology

Volumn 54, Issue 9, 2016, Pages 1596-1605

  Pattananandecha, Thanawat ^a   Sirilun, Sasithorn ^a   Duangjitcharoen, Yodsawee ^a   Sivamaruthi, Bhagavathi Sundaram ^a   Suwannalert, Prasit ^b   Peerajan, Sartjin ^c   Chaiyasut, Chaiyavat ^a  

^a CHIANG MAI UNIVERSITY   (Thailand)

^b Mahidol University   (Thailand)

^c Health Innovation Institute   (Thailand)

Author keywords

Helianthus tuberosus L; prebiotics; probiotics

Indexed keywords

AZO REDUCTASE; BETA GLUCURONIDASE; CARBOXYLIC ACID; CHEMICAL COMPOUND; INDOLE; INULIN; MICROBIAL ENZYME; NITROREDUCTASE; PARA CRESOL; PHENOL; PUTREFACTIVE COMPOUND; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; AZOXYMETHANE;

ABERRANT CRYPT FOCUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIUM IDENTIFICATION; BIFIDOBACTERIACEAE; BODY WEIGHT; CANCER INHIBITION; CECAL WEIGHT; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME INHIBITION; ESCHERICHIA COLI; INTESTINE FLORA; LACTOBACILLUS; MALE; MICROSCOPY; NONHUMAN; ORGAN WEIGHT; PH MEASUREMENT; RAT; SALMONELLA ENTERICA; TREATMENT RESPONSE; ABERRANT CRYPT FOCI; ANIMAL; BACTERIAL LOAD; BACTERIUM; BIOMASS; CHEMICALLY INDUCED; CLASSIFICATION; COLON; COLONIC NEOPLASMS; DISEASE MODEL; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; HYDROLYSIS; MICROBIOLOGY; PATHOLOGY; SPRAGUE DAWLEY RAT; TIME FACTOR;

ABERRANT CRYPT FOCI; ANIMALS; ANTICARCINOGENIC AGENTS; AZOXYMETHANE; BACTERIA; BACTERIAL LOAD; BIOMASS; COLON; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; GASTROINTESTINAL MICROBIOME; HYDROLYSIS; INULIN; MALE; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 84955070529     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2015.1110597     Document Type: Article

References (75)

1. J.Ahn, R.Sinha, Z.Pei, C.Dominianni, J.Wu, J.Shi, J.J.Goedert, R.B.Hayes, L.Yang. 2013. Human gut microbiome and risk for colorectal cancer. J Natl Cancer Inst. 105:1907–1911.
2. A.M.Berggren, I.M.E.Björck, E.M.G.L.Nyman, B.O.Eggum. 1993. Short-chain fatty acid content and pH in caecum of rats given various sources of carbohydrates. J Sci Food Agric. 63:397–406.
3. R.P.Bird 1987. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen:preliminary findings. Cancer Lett. 37:147–151.
4. M.Bonnet, E.Buc, P.Sauvanet, C.Darcha, D.Dubois, B.Pereira, P.Déchelotte, R.Bonnet, D.Pezet, Darfeuille-A.Michaud. 2014. Colonization of the human gut by E. coli and colorectal cancer risk. Clin Cancer Res. 20:859–867.
5. J.Boren, W.N.Lee, S.Bassilian, J.J.Centelles, S.Lim, S.Ahmed, L.G.Boros, M.Cascante. 2003. The stable isotope-based dynamic metabolic profile of butyrate-induced HT29 cell differentiation. J Biol Chem. 278:28395–28402.
6. A.J.Burns, I.R.Rowland 2000. Anti-carcinogenicity of probiotics and prebiotics. Curr Issues Intest Microbiol. 1:13–24.
7. T.R.Callaway, T.S.Edrington, R.B.Harvey, R.C.Anderson, D.J.Nisbet. 2012. Prebiotics in food animals, a potential to reduce foodborne pathogens and disease. Rom Biotech Lett. 17:7808–7816.
8. J.M.Campbell, G.C.FaheyJr, B.W.Wolf 1997. Selected indigestible oligosaccharides affect large bowel mass, cecal and fecal short-chain fatty acids, pH and microflora in rats. J Nutr. 127:130–136.
9. C.Cerini, L.Dou, F.Anfosso, F.Sabatier, V.Moal, G.Glorieux, S.DeSmet R, R.Vanholder, Dignat-F.George, J.Sampol,. 2004. P-Cresol, a uremic retention solute, alters the endothelial barrier function in vitro. Thromb Haemost. 92:140–150.
10. A.Challa, D.R.Rao, C.B.Chawan, L.Shackelford. 1997. Bifidobacterium longum and lactulose suppress azoxymethane-induced colonic aberrant crypt foci in rats. Carcinogenesis 18:517–521.
11. M.Comalada, E.Bailón, O.de Haro, F.Lara-Villoslada, J.Xaus, A.Zarzuelo, J.Gálvez. 2006. The effects of short-chain fatty acids on colon epithelial proliferation and survival depend on the cellular phenotype. J Cancer Res Clin Oncol. 132:487–497.
12. H.Danilcenko, E.Jarienė, P.Aleknaviciene. 2008. Quality of Jerusalem artichoke (Helianthus tuberosus L.) tubers in relation to storage conditions. Not Bot Hort Agrobot Cluj. 36:23–27.
13. A.de Morenode LeBlanc, G.Perdigon 2005. Reduction of beta-glucuronidase and nitroreductase activity by yoghurt in a murine colon cancer model. Biocell 29:15–24.
14. V.De Preter, T.Vanhoutte, G.Huys, J.Swings, L.De Vuyst, P.Rutgeerts, K.Verbeke. 2007. Effects of Lactobacillus casei Shirota, Bifidobacterium breve, and oligofructose-enriched inulin on colonic nitrogen-protein metabolism in healthy humans. Am J Physiol Gastrointest Liver Physiol. 292:G358–G368.
15. K.Deeptha, M.Kamaleeswari, M.Sengottuvelan, N.Nalini. 2006. Dose dependent inhibitory effect of dietary caraway on 1,2-dimethylhydrazine induced colonic aberrant crypt foci and bacterial enzyme activity in rats. Invest New Drugs 24:479–488.
16. H.Duan, C.A.Heckman, L.M.Boxer 2005. Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas. Mol Cell Biol. 25:1608–1619.
17. A.P.Femia, C.Luceri, P.Dolara, A.Giannini, A.Biggeri, M.Salvadori, Y.Clune, K.J.Collins, M.Paglierani, G.Caderni. 2002. Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis 23:1953–1960.
18. K.Y.Fung, G.V.Brierley, S.Henderson, P.Hoffmann, S.R.McColl, T.Lockett, R.Head, L.Cosgrove. 2011. Butyrate-induced apoptosis in HCT116 colorectal cancer cells includes induction of a cell stress response. J Proteome Res. 10:1860–1869.
19. J.Geng, H.Fan, X.Tang, H.Zhai, Z.Zhang. 2013. Diversified pattern of the human colorectal cancer microbiome. Gut Pathog. 5:2.
20. G.R.Gibson, M.B.Roberfroid 1995. Dietary modulation of the human colonic microbiota:introducing the concept of prebiotics. J Nutr. 125:1401–1412.
21. G.R.Gibson, K.P.Scott, R.A.Rastall, K.M.Tuohy, A.Hotchkiss, Dubert-A.Ferrandon, M.Gareau, E.F.Murphy, D.Saulnier, G.Loh,. 2010. Dietary prebiotics:current status and new definition. Food Sci Technol Bull Funct Foods 7:1–19.
22. E.Giovannucci, E.B.Rimm, M.J.Stampfer, G.A.Colditz, A.Ascherio, W.C.Willett. 1994. Intake of fat, meat, and fiber in relation to risk of colon cancer in men. Cancer Res. 54:2390–2397.
23. S.L.Gorbach, B.R.Goldin 1990. The intestinal microflora and the colon cancer connection. Rev Infect Dis. 12:S252–S261.
24. C.M.Guinane, P.D.Cotter 2013. Role of the gut microbiota in health and chronic gastrointestinal disease:understanding a hidden metabolic organ. Therap Adv Gastroenterol. 6:295–308.
25. P.Haberer, M.du Toit, L.M.Dicks, F.Ahrens, W.H.Holzapfel. 2003. Effect of potentially probiotic lactobacilli on faecal enzyme activity in minipigs on a high-fat, high-cholesterol diet-a preliminary in vivo trial. Int J Food Microbiol. 87:287–291.
26. A.Henningsson, I.Bjorck, M.Nyman 2001. Short-chain fatty acid formation at fermentation of indigestible carbohydrates. Scand J Nutr. 45:165–168.
27. E.Hijova, A.Chmelarova 2007. Short chain fatty acids and colonic health. Bratisl Lek Listy 108:354–358.
28. E.Hijova, V.Szabadosova, L.Strojny, A.Bomba. 2014. Changes chemopreventive markers in colorectal cancer development after inulin supplementation. Bratisl Lek Listy 115:76–79.
29. F.Hirschhaeuser, U.G.Sattler, W.Mueller-Klieser 2011. Lactate:a metabolic key player in cancer. Cancer Res. 71:6921–6925.
30. R.Hughes, E.A.Magee, S.Bingham 2000. Protein degradation in the large intestine:relevance to colorectal cancer. Curr Issues Intest Microbiol. 1:51–58.
31. R.Hughes, I.R.Rowland 2000. Metabolic activities of the gut microflora in relation to cancer. Microb Ecol Health D 12:179–185.
32. T.Khuhaprema, S.Sangrajrang, S.Lalitwongsa, V.Chokvanitphong, T.Raunroadroong, T.Ratanachu-Ek, R.Muwonge, E.Lucas, C.Wild, R.Sankaranarayanan. 2014. Organised colorectal cancer screening in Lampang Province, Thailand:preliminary results from a pilot implementation programme. BMJ Open 4:e003671.
33. T.Khuhaprema, P.Srivatanakul 2008. Colon and rectum cancer in Thailand:an overview. Jpn J Clin Oncol. 38:237–243.
34. P.V.Kirjavainen, T.Arvola, S.J.Salminen, E.Isolauri. 2002. Aberrant composition of gut microbiota of allergic infants:a target of bifidobacterial therapy at weaning? Gut 51:51–55.
35. S.C.Larsson, A.Wolk 2006. Meat consumption and risk of colorectal cancer:a meta-analysis of prospective studies. Int J Cancer 119:2657–2664.
36. S.M.Lee, W.K.Lee 2001. Effects of lactic acid bacteria on intestinal microbial enzyme activity and composition in rats treated with azoxymethane. J Microbiol. 39:154–161.
37. E.S.Lima, D.S.P.Abdalla 2002. High-performance liquid chromatography of fatty acids in biological samples. Anal Chim Acta. 465:81–91.
38. G.Loh, M.Eberhard, R.M.Brunner, U.Hennig, S.Kuhla, B.Kleessen, C.C.Metges. 2006. Inulin alters the intestinal microbiota and short-chain fatty acid concentrations in growing pigs regardless of their basal diet. J Nutr. 136:1198–1202.
39. D.L.Mager 2006. Bacteria and cancer:cause, coincidence or cure? A review. J Transl Med. 4:14. DOI:10.1186/1479-5876-4-14.
40. I.C.McCall, A.Betanzos, D.A.Weber, P.Nava, G.W.Miller, C.A.Parkos. 2009. Effects of phenol on barrier function of a human intestinal epithelial cell line correlate with altered tight junction protein localization. Toxicol Appl Pharmacol. 241:61–70.
41. F.Nagengast, M.Grubben, I.van Munster 1995. Role of bile acids in colorectal carcinogenesis. Eur J Cancer 31:1067–1070.
42. K.R.Niness 1999. Inulin and oligofructose:what are they? J Nutr. 129:1402S–1406S.
43. A.Nowak, Z.Libudzisz 2006. Influence of phenol, p-cresol and indole on growth and survival of intestinal lactic acid bacteria. Anaerobe 12:80–84.
44. A.Nowak, Z.Libudzisz 2007. Ability of intestinal lactic bacteria to bind or/and metabolize phenol and p-cresol. Ann Microbiol. 57:329–335.
45. X.Pan, F.Chen, T.Wu, H.Tang, Z.Zhao. 2009. Prebiotic oligosaccharides change the concentrations of short-chain fatty acids and the microbial population of mouse bowel. J Zhejiang Univ Sci B. 10:258–263.
46. T.Pang, S.T.Leach, T.Katz, A.S.Day, C.Y.Ooi. 2014. Fecal biomarkers of intestinal health and disease in children. Front Pediatr. 2:6. doi:10.3389/fped.2014.00006
47. T.Pattananandecha, S.Sirilun, B.S.Sivamaruthi, P.Suwannalert, P.SartjinPeerajan S, C.Chaiyasut. 2015. Hydrolyzed inulin with different degree of polymerization as prebiotic for Lactobacillus plantarum. J Pure Appl Microbiol. 9:973–979.
48. E.L.Propst, E.A.Flickinger, L.L.Bauer, N.R.Merchen, G.C.FaheyJr. 2003. A dose–response experiment evaluating the effects of oligofructose and inulin on nutrient digestibility, stool quality, and fecal protein catabolites in healthy adult dogs. J Anim Sci. 81:3057–3066.
49. F.Rafii, W.Franklin, C.E.Cerniglia 1990. Azoreductase activity of anaerobic bacteria isolated from human intestinal microflora. Appl Environ Microbiol. 56:2146–2151.
50. B.Reddy, R.Hamid, C.V.Rao 1997. Effect of dietary oligofructose and inulin on colonic preneoplastic aberrant crypt foci inhibition. Carcinogenesis 18:1371–1374.
51. M.Rossi, C.Corradini, A.Amaretti, M.Nicolini, A.Pompei, S.Zanoni, D.Matteuzzi. 2005. Fermentation of fructooligosaccharides and inulin by bifidobacteria:a comparative study of pure and fecal cultures. Appl Environ Microbiol. 71:6150–6158.
52. I.R.Rowland, C.J.Rumney, J.T.Coutts, L.C.Lievense. 1998. Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis 19:281–285.
53. F.M.Ruemmele, S.Schwartz, E.G.Seidman, S.Dionne, E.Levy, M.J.Lentze. 2003. Butyrate induced Caco-2 cell apoptosis is mediated via the mitochondrial pathway. Gut 52:94–100.
54. H.Ruppin, S.Bar-Meir, K.H.Soergel, C.M.Wood, M.G.SchmittJr. 1980. Absorption of short-chain fatty acids by the colon. Gastroenterology 78:1500–1507.
55. J.M.Saavedra, N.A.Bauman, I.Oung, J.A.Perman, R.H.Yolken. 1994. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 344:1046–1049.
56. M.S.Sandhu, I.R.White, K.Mc Pherson 2001. Systematic review of the prospective cohort studies on meat consumption and colorectal cancer risk:a meta-analytical approach. Cancer Epidemiol Biomarkers Prev. 10:439–446.
57. R.F.Schwabe, C.Jobin 2013. The microbiome and cancer. Nat Rev Cancer 13:800–802.
58. S.Siavoshian, J.Segain, M.Kornprobst, C.Bonnet, C.Cherbut, J.P.Galmiche, H.M.Blottière. 2000. Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells:induction of cyclin D3 and p21 expression. Gut 46:507–514.
59. J.Slavin 2013. Fiber and prebiotics:mechanisms and health benefits. Nutrients 5:1417–1435.
60. K.S.Swanson, C.M.Grieshop, E.A.Flickinger, L.L.Bauer, H.P.Healy, K.A.Dawson, N.R.Merchen, G.C.FaheyJr. 2002. Supplemental fructooligosaccharides and mannanoligosaccharides influence immune function, ileal and total tract nutrient digestibilities, microbial populations and concentrations of protein catabolites in the large bowel of dogs. J Nutr. 132:980–989.
61. D.Topping, P.Clifton 2001. Short-chain fatty acids and human colonic function:roles of resistant starch and nonstarch polysaccharides. Physiol Rev. 81:1031–1064.
62. M.Uccello, G.Malaguarnera, F.Basile, V.D’agata, M.Malaguarnera, G.Bertino, M.Vacante, F.Drago, A.Biondi. 2012. Potential role of probiotics on colorectal cancer prevention. BMC Surg. 12:S35.
63. T.Vande Wiele, N.Boon, S.Possemiers, H.Jacobs, W.Verstraete. 2007. Inulin-type fructans of longer degree of polymerization exert more pronounced in vitro prebiotic effects. J Appl Microbiol. 102:452–460.
64. J.Van Loo 2004. The specificity of the interaction with intestinal bacterial fermentation by prebiotics determines their physiological efficacy. Nutr Res Rev. 17:89–98.
65. J.Van Loo, P.Coussement, L.de Leenheer, H.Hoebregs, G.Smits. 1995. On the presence of inulin and oligofructose as natural ingredients in the western diet. Crit Rev Food Sci Nutr. 35:525–552.
66. M.Verghese, D.R.Rao, C.B.Chawan, L.Shackelford. 2002a. Dietary inulin suppresses azoxymethane-induced preneoplastic aberrant crypt foci in mature Fisher 344 rats. J Nutr. 132:2804–2808.
67. M.Verghese, D.R.Rao, C.B.Chawan, L.L.Williams, L.Shackelford. 2002b. Dietary inulin suppresses azoxymethane-induced aberrant crypt foci and colon tumors at the promotion stage in young Fisher 344 rats. J Nutr. 132:2809–2813.
68. M.Verghese, L.T.Walker, L.Shackelford, C.B.Chawan. 2005. Inhibitory effects of nondigestible carbohydrates of different chain lengths on azoxymethane-induced aberrant crypt foci in Fisher 344 rats. Nutr Res. 25:859–868.
69. M.Waldecker, T.Kautenburger, H.Daumann, C.Busch, D.Schrenk. 2008. Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon. J Nutr Biochem. 19:587–593.
70. K.Whitlock, R.S.Gill, D.W.Birch, S.Karmali. 2012. The association between obesity and colorectal cancer. Gastroenterol Res Pract. 2012:1–6.
71. K.Windey, V.De Preter, K.Verbeke 2012. Relevance of protein fermentation to gut health. Mol Nutr Food Res 56:184–196.
72. J.M.Wong, R.de Souza, C.W.Kendall, A.Emam, D.J.Jenkins. 2006. Colonic health:fermentation and short chain fatty acids. J Clin Gastroenterol. 40:235–243.
73. J.P.Zackular, M.A.Rogers, M.T.Ruffin4th, P.D.Schloss. 2014. The human gut microbiome as a screening tool for colorectal cancer. Cancer Prev Res (Phila). 7:1112–1121.
74. X.Zhang, Y.Ohta 1993. Antimutagenicity of cell fractions of microorganisms on potent mutagenic pyrolysates. Mutat Res. 298:247–253.
75. Y.Zhao, J.Hasjim, L.Li, J.L.Jane, S.Hendrich, D.F.Birt. 2011. Inhibition of azoxymethane-induced preneoplastic lesions in the rat colon by a cooked stearic acid complexed high-amylose cornstarch. J Agric Food Chem. 59:9700–9708.